chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Malaise, Myalgia
Clinical narrative: not feeling well; like flu onset; arm sore; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not feeling well), INFLUENZA LIKE ILLNESS (like flu onset) and MYALGIA (arm sore) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0428212A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included WARFARIN SODIUM (COUMADIN) for an unknown indication.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced MALAISE (not feeling well), INFLUENZA LIKE ILLNESS (like flu onset) and MYALGIA (arm sore). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MALAISE (not feeling well), INFLUENZA LIKE ILLNESS (like flu onset) and MYALGIA (arm sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Experienced drip on arm before injecting the vaccine; Less dose given; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (Experienced drip on arm before injecting the vaccine) and UNDERDOSE (Less dose given) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007CZIA) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced UNDERDOSE (Experienced drip on arm before injecting the vaccine) and UNDERDOSE (Less dose given). At the time of the report, UNDERDOSE (Experienced drip on arm before injecting the vaccine) and UNDERDOSE (Less dose given) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment drugs were reported.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Blood pressure measurement, Dyskinesia, Dysphagia, Feeling hot
Clinical narrative: his muscles were hurting; fever was 104.5degF; This morning he woke up around 2am shaking; had severe joint pain; very hot to touch; very wet and sweaty; he felt very nauseous; trouble moving and had constricted movements; difficulty swallowing; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (his muscles were hurting), PYREXIA (fever was 104.5degF), TREMOR (This morning he woke up around 2am shaking), ARTHRALGIA (had severe joint pain) and FEELING HOT (very hot to touch) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001C21A and Lot# 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (his muscles were hurting), PYREXIA (fever was 104.5degF), TREMOR (This morning he woke up around 2am shaking), ARTHRALGIA (had severe joint pain), FEELING HOT (very hot to touch), HYPERHIDROSIS (very wet and sweaty), NAUSEA (he felt very nauseous), DYSKINESIA (trouble moving and had constricted movements) and DYSPHAGIA (difficulty swallowing). At the time of the report, MYALGIA (his muscles were hurting), PYREXIA (fever was 104.5degF), TREMOR (This morning he woke up around 2am shaking), ARTHRALGIA (had severe joint pain), FEELING HOT (very hot to touch), HYPERHIDROSIS (very wet and sweaty), NAUSEA (he felt very nauseous), DYSKINESIA (trouble moving and had constricted movements) and DYSPHAGIA (difficulty swallowing) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: abnormal (abnormal) 112/60. On an unknown date, Heart rate: abnormal (abnormal) 66. On an unknown date, Pyrexia: high degree Celsius (High) 102.8 degree fahrenheit.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment given included Ibuprofen pill,800mg liquid motrin, cold compress, Icy water and Cold liquids.   This case was linked to MOD-2021-083418, MOD-2021-083439 (Linked Report). This case was linked to MOD-2021-083967 (Patient Link).
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate, Hyperhidrosis, Myalgia, Nausea, Pyrexia
Clinical narrative: his muscles were hurting; fever was 104.5degF; This morning he woke up around 2am shaking; had severe joint pain; very hot to touch; very wet and sweaty; he felt very nauseous; trouble moving and had constricted movements; difficulty swallowing; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (his muscles were hurting), PYREXIA (fever was 104.5degF), TREMOR (This morning he woke up around 2am shaking), ARTHRALGIA (had severe joint pain) and FEELING HOT (very hot to touch) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001C21A and Lot# 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (his muscles were hurting), PYREXIA (fever was 104.5degF), TREMOR (This morning he woke up around 2am shaking), ARTHRALGIA (had severe joint pain), FEELING HOT (very hot to touch), HYPERHIDROSIS (very wet and sweaty), NAUSEA (he felt very nauseous), DYSKINESIA (trouble moving and had constricted movements) and DYSPHAGIA (difficulty swallowing). At the time of the report, MYALGIA (his muscles were hurting), PYREXIA (fever was 104.5degF), TREMOR (This morning he woke up around 2am shaking), ARTHRALGIA (had severe joint pain), FEELING HOT (very hot to touch), HYPERHIDROSIS (very wet and sweaty), NAUSEA (he felt very nauseous), DYSKINESIA (trouble moving and had constricted movements) and DYSPHAGIA (difficulty swallowing) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: abnormal (abnormal) 112/60. On an unknown date, Heart rate: abnormal (abnormal) 66. On an unknown date, Pyrexia: high degree Celsius (High) 102.8 degree fahrenheit.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment given included Ibuprofen pill,800mg liquid motrin, cold compress, Icy water and Cold liquids.   This case was linked to MOD-2021-083418, MOD-2021-083439 (Linked Report). This case was linked to MOD-2021-083967 (Patient Link).
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: his muscles were hurting; fever was 104.5degF; This morning he woke up around 2am shaking; had severe joint pain; very hot to touch; very wet and sweaty; he felt very nauseous; trouble moving and had constricted movements; difficulty swallowing; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (his muscles were hurting), PYREXIA (fever was 104.5degF), TREMOR (This morning he woke up around 2am shaking), ARTHRALGIA (had severe joint pain) and FEELING HOT (very hot to touch) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001C21A and Lot# 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (his muscles were hurting), PYREXIA (fever was 104.5degF), TREMOR (This morning he woke up around 2am shaking), ARTHRALGIA (had severe joint pain), FEELING HOT (very hot to touch), HYPERHIDROSIS (very wet and sweaty), NAUSEA (he felt very nauseous), DYSKINESIA (trouble moving and had constricted movements) and DYSPHAGIA (difficulty swallowing). At the time of the report, MYALGIA (his muscles were hurting), PYREXIA (fever was 104.5degF), TREMOR (This morning he woke up around 2am shaking), ARTHRALGIA (had severe joint pain), FEELING HOT (very hot to touch), HYPERHIDROSIS (very wet and sweaty), NAUSEA (he felt very nauseous), DYSKINESIA (trouble moving and had constricted movements) and DYSPHAGIA (difficulty swallowing) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: abnormal (abnormal) 112/60. On an unknown date, Heart rate: abnormal (abnormal) 66. On an unknown date, Pyrexia: high degree Celsius (High) 102.8 degree fahrenheit.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment given included Ibuprofen pill,800mg liquid motrin, cold compress, Icy water and Cold liquids.   This case was linked to MOD-2021-083418, MOD-2021-083439 (Linked Report). This case was linked to MOD-2021-083967 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Might administer dose after 42 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Might administer dose after 42 days) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Might administer dose after 42 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Might administer dose after 42 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain
Clinical narrative: Redness at site of injection; Pain in arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness at site of injection) and VACCINATION SITE PAIN (Pain in arm of injection) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at site of injection) and VACCINATION SITE PAIN (Pain in arm of injection). At the time of the report, VACCINATION SITE ERYTHEMA (Redness at site of injection) and VACCINATION SITE PAIN (Pain in arm of injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.   This case was linked to MOD-2021-084119 (Patient Link).
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy to vaccine, Arthralgia, Back pain, Chills, Dizziness
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (muscle spasms waste down), MOVEMENT DISORDER (can hardly walk), NERVOUSNESS (shaky at times), MUSCLE SPASMS (back spasms) and BACK PAIN (Lower back pain) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. Concurrent medical conditions included Hypertension since 30-Jan-2015, Type 1 diabetes mellitus since 30-May-1999 and Drug allergy (opioid allergy). Concomitant products included INSULIN GLARGINE (LANTUS), INSULIN LISPRO (HUMALOG) and DULOXETINE HYDROCHLORIDE (CYMBALTA) for Diabetes, LISINOPRIL for Hypertension, TOPIRAMATE (TOPAMAX) for Migraine. On 31-Mar-2021 at 4:30 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced MUSCLE SPASMS (muscle spasms waste down), MOVEMENT DISORDER (can hardly walk), NERVOUSNESS (shaky at times), MUSCLE SPASMS (back spasms), BACK PAIN (Lower back pain), MYALGIA (Body aches), CHILLS (Chills) and ARTHRALGIA (joint pain). On 08-Apr-2021, the patient experienced ALLERGY TO VACCINE (Allergic reaction to vaccine). On 09-Apr-2021, the patient experienced MUSCLE SPASMS (spasms throughout body uncontrollably). On an unknown date, the patient experienced PAIN (Extreme pain joints, legs, hips). The patient was treated with Physical therapy for Movement disorder; Physical therapy for Back pain; Physical therapy for Pain; Physical therapy for Pain and Physical therapy for Arthralgia. On 01-Apr-2021, CHILLS (Chills) had resolved. At the time of the report, MUSCLE SPASMS (muscle spasms waste down), MOVEMENT DISORDER (can hardly walk), NERVOUSNESS (shaky at times), MUSCLE SPASMS (back spasms), ALLERGY TO VACCINE (Allergic reaction to vaccine), MUSCLE SPASMS (spasms throughout body uncontrollably) and MYALGIA (Body aches) outcome was unknown and BACK PAIN (Lower back pain), PAIN (Extreme pain joints, legs, hips) and ARTHRALGIA (joint pain) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. This case was linked to MOD-2021-166743. Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Significant Fu added. On 26-May-2021: Case merged with earlier duplicate case. Case marked for deletion.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Joint stiffness, Mobility decreased, Movement disorder, Muscle spasms
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (muscle spasms waste down), MOVEMENT DISORDER (can hardly walk), NERVOUSNESS (shaky at times), MUSCLE SPASMS (back spasms) and BACK PAIN (Lower back pain) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. Concurrent medical conditions included Hypertension since 30-Jan-2015, Type 1 diabetes mellitus since 30-May-1999 and Drug allergy (opioid allergy). Concomitant products included INSULIN GLARGINE (LANTUS), INSULIN LISPRO (HUMALOG) and DULOXETINE HYDROCHLORIDE (CYMBALTA) for Diabetes, LISINOPRIL for Hypertension, TOPIRAMATE (TOPAMAX) for Migraine. On 31-Mar-2021 at 4:30 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced MUSCLE SPASMS (muscle spasms waste down), MOVEMENT DISORDER (can hardly walk), NERVOUSNESS (shaky at times), MUSCLE SPASMS (back spasms), BACK PAIN (Lower back pain), MYALGIA (Body aches), CHILLS (Chills) and ARTHRALGIA (joint pain). On 08-Apr-2021, the patient experienced ALLERGY TO VACCINE (Allergic reaction to vaccine). On 09-Apr-2021, the patient experienced MUSCLE SPASMS (spasms throughout body uncontrollably). On an unknown date, the patient experienced PAIN (Extreme pain joints, legs, hips). The patient was treated with Physical therapy for Movement disorder; Physical therapy for Back pain; Physical therapy for Pain; Physical therapy for Pain and Physical therapy for Arthralgia. On 01-Apr-2021, CHILLS (Chills) had resolved. At the time of the report, MUSCLE SPASMS (muscle spasms waste down), MOVEMENT DISORDER (can hardly walk), NERVOUSNESS (shaky at times), MUSCLE SPASMS (back spasms), ALLERGY TO VACCINE (Allergic reaction to vaccine), MUSCLE SPASMS (spasms throughout body uncontrollably) and MYALGIA (Body aches) outcome was unknown and BACK PAIN (Lower back pain), PAIN (Extreme pain joints, legs, hips) and ARTHRALGIA (joint pain) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. This case was linked to MOD-2021-166743. Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Significant Fu added. On 26-May-2021: Case merged with earlier duplicate case. Case marked for deletion.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nervousness, Pain, Pyrexia, Restlessness
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (muscle spasms waste down), MOVEMENT DISORDER (can hardly walk), NERVOUSNESS (shaky at times), MUSCLE SPASMS (back spasms) and BACK PAIN (Lower back pain) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. Concurrent medical conditions included Hypertension since 30-Jan-2015, Type 1 diabetes mellitus since 30-May-1999 and Drug allergy (opioid allergy). Concomitant products included INSULIN GLARGINE (LANTUS), INSULIN LISPRO (HUMALOG) and DULOXETINE HYDROCHLORIDE (CYMBALTA) for Diabetes, LISINOPRIL for Hypertension, TOPIRAMATE (TOPAMAX) for Migraine. On 31-Mar-2021 at 4:30 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced MUSCLE SPASMS (muscle spasms waste down), MOVEMENT DISORDER (can hardly walk), NERVOUSNESS (shaky at times), MUSCLE SPASMS (back spasms), BACK PAIN (Lower back pain), MYALGIA (Body aches), CHILLS (Chills) and ARTHRALGIA (joint pain). On 08-Apr-2021, the patient experienced ALLERGY TO VACCINE (Allergic reaction to vaccine). On 09-Apr-2021, the patient experienced MUSCLE SPASMS (spasms throughout body uncontrollably). On an unknown date, the patient experienced PAIN (Extreme pain joints, legs, hips). The patient was treated with Physical therapy for Movement disorder; Physical therapy for Back pain; Physical therapy for Pain; Physical therapy for Pain and Physical therapy for Arthralgia. On 01-Apr-2021, CHILLS (Chills) had resolved. At the time of the report, MUSCLE SPASMS (muscle spasms waste down), MOVEMENT DISORDER (can hardly walk), NERVOUSNESS (shaky at times), MUSCLE SPASMS (back spasms), ALLERGY TO VACCINE (Allergic reaction to vaccine), MUSCLE SPASMS (spasms throughout body uncontrollably) and MYALGIA (Body aches) outcome was unknown and BACK PAIN (Lower back pain), PAIN (Extreme pain joints, legs, hips) and ARTHRALGIA (joint pain) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. This case was linked to MOD-2021-166743. Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Significant Fu added. On 26-May-2021: Case merged with earlier duplicate case. Case marked for deletion.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Product administration error, Underdose
Clinical narrative: the dose from the injection spilled down his arm; the dose from the injection spilled down his arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of UNDERDOSE (the dose from the injection spilled down his arm) and PRODUCT ADMINISTRATION ERROR (the dose from the injection spilled down his arm) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced UNDERDOSE (the dose from the injection spilled down his arm) and PRODUCT ADMINISTRATION ERROR (the dose from the injection spilled down his arm). At the time of the report, UNDERDOSE (the dose from the injection spilled down his arm) and PRODUCT ADMINISTRATION ERROR (the dose from the injection spilled down his arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications of the patient were not provided. No concomitant medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Follow-up received contains reporter contact information.
Sex: F
Vaccine: COVID19
Symptoms: Accident, Anxiety, Blood glucose increased, Confusional state
Clinical narrative: Losing judgement; had few minor accidents; Is scared, and does not want to die on the street; High sugar levels; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (High sugar levels), CONFUSIONAL STATE (Losing judgement), ACCIDENT (had few minor accidents) and ANXIETY (Is scared, and does not want to die on the street) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced BLOOD GLUCOSE INCREASED (High sugar levels). On an unknown date, the patient experienced CONFUSIONAL STATE (Losing judgement), ACCIDENT (had few minor accidents) and ANXIETY (Is scared, and does not want to die on the street). At the time of the report, BLOOD GLUCOSE INCREASED (High sugar levels), CONFUSIONAL STATE (Losing judgement), ACCIDENT (had few minor accidents) and ANXIETY (Is scared, and does not want to die on the street) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  No treatment medications  were provided.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, SARS-CoV-2 test
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Headache, Kidney absent, Hypertension, High cholesterol and Diabetes. Concomitant products included PANTOPRAZOLE for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 14-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2021, SARS-CoV-2 test: Negative and (Negative) current covid test.         Relevant concomitant product usage were not reported by the reporter. No treatment details were added.    Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow up received on 16-June-2021, contains no significant information.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Headache, Irritability, Ocular hyperaemia, Pain in extremity
Clinical narrative: her right red eye like a broken blood vessel; she feels warm; she feels irritated; arm hurts; mild headache; This spontaneous case was reported by a consumer and describes the occurrence of OCULAR HYPERAEMIA (her right red eye like a broken blood vessel), FEELING HOT (she feels warm), IRRITABILITY (she feels irritated), PAIN IN EXTREMITY (arm hurts) and HEADACHE (mild headache) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     Concomitant products included VITAMIN B12 NOS and ASCORBIC ACID (VITAMIIN C) for an unknown indication.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced HEADACHE (mild headache). On 21-Apr-2021, the patient experienced OCULAR HYPERAEMIA (her right red eye like a broken blood vessel), FEELING HOT (she feels warm), IRRITABILITY (she feels irritated) and PAIN IN EXTREMITY (arm hurts). At the time of the report, OCULAR HYPERAEMIA (her right red eye like a broken blood vessel), FEELING HOT (she feels warm), IRRITABILITY (she feels irritated), PAIN IN EXTREMITY (arm hurts) and HEADACHE (mild headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant medication included Vitamin D. Treatment information not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Pain in extremity, Peripheral swelling, Pruritus
Clinical narrative: itchy; 6 in x4in inflamed area that was swollen; 6 in x4in inflamed area that was swollen; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy), PERIPHERAL SWELLING (6 in x4in inflamed area that was swollen), INFLAMMATION (6 in x4in inflamed area that was swollen) and PAIN IN EXTREMITY (sore arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018BZIA) for COVID-19 vaccination.     Concomitant products included EZETIMIBE for Cholesterol, UBIDECARENONE (COQ10 [UBIDECARENONE]) for Enzyme supplementation, COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for Vitamin supplementation.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced PRURITUS (itchy), PERIPHERAL SWELLING (6 in x4in inflamed area that was swollen), INFLAMMATION (6 in x4in inflamed area that was swollen) and PAIN IN EXTREMITY (sore arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PRURITUS (itchy), PERIPHERAL SWELLING (6 in x4in inflamed area that was swollen) and INFLAMMATION (6 in x4in inflamed area that was swollen) outcome was unknown and PAIN IN EXTREMITY (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other concomitant product included immune system support for supplementation. Patient was treated with Arnica and ice.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: intense muscle pain; ntense joint pain; Chills; Fever; Some nausea; Mild headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (intense muscle pain), ARTHRALGIA (ntense joint pain), CHILLS (Chills), PYREXIA (Fever) and NAUSEA (Some nausea) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     no medical history information was reported.    On 17-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Apr-2021, the patient experienced MYALGIA (intense muscle pain), ARTHRALGIA (ntense joint pain), CHILLS (Chills), PYREXIA (Fever), NAUSEA (Some nausea), HEADACHE (Mild headache) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 21-Apr-2021, MYALGIA (intense muscle pain), ARTHRALGIA (ntense joint pain), CHILLS (Chills), PYREXIA (Fever), NAUSEA (Some nausea), HEADACHE (Mild headache) and FATIGUE (fatigue) had resolved.            No concomitant medication was provided Treatment received : phenergan
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: intense muscle pain; ntense joint pain; Chills; Fever; Some nausea; Mild headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (intense muscle pain), ARTHRALGIA (ntense joint pain), CHILLS (Chills), PYREXIA (Fever) and NAUSEA (Some nausea) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     no medical history information was reported.    On 17-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Apr-2021, the patient experienced MYALGIA (intense muscle pain), ARTHRALGIA (ntense joint pain), CHILLS (Chills), PYREXIA (Fever), NAUSEA (Some nausea), HEADACHE (Mild headache) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 21-Apr-2021, MYALGIA (intense muscle pain), ARTHRALGIA (ntense joint pain), CHILLS (Chills), PYREXIA (Fever), NAUSEA (Some nausea), HEADACHE (Mild headache) and FATIGUE (fatigue) had resolved.            No concomitant medication was provided Treatment received : phenergan
Sex: U
Vaccine: COVID19
Symptoms: Wrong technique in product usage process
Clinical narrative: Vaccine administered without proper thawing; Vaccine administered after being shaken; This spontaneous case was reported by a physician and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccine administered without proper thawing) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccine administered after being shaken) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047b21a) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccine administered without proper thawing) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccine administered after being shaken). At the time of the report, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccine administered without proper thawing) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccine administered after being shaken) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Pyrexia, Tremor
Clinical narrative: Tremor of hands; Aching in knees; Fever; Headache; This spontaneous case was reported by a physician and describes the occurrence of TREMOR (Tremor of hands), ARTHRALGIA (Aching in knees), PYREXIA (Fever) and HEADACHE (Headache) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for an unknown indication.    Concurrent medical conditions included Smoker (Tobacco use/cigarettes  one packet daily) since 1973.   In 2018, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TREMOR (Tremor of hands), ARTHRALGIA (Aching in knees), PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, TREMOR (Tremor of hands), ARTHRALGIA (Aching in knees), PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were provided. No treatment information was provided. The action taken for mRNA-1273 was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow up information was received on 24 May 2021 contains non significant information.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: fever; fatigue; headache; Chills; nausea; vomiting; Muscle pain; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), PYREXIA (fever), FATIGUE (fatigue) and HEADACHE (headache) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 042B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), CHILLS (Chills) and NAUSEA ( nausea). 14-Apr-2021, the patient experienced VOMITING (vomiting). On 19-Apr-2021, the patient experienced PYREXIA (fever) and FATIGUE (fatigue). 19-Apr-2021, the patient experienced HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and PROMETHAZINE (PHENERGAN [PROMETHAZINE]) at a dose of 1 dosage form. On 17-Apr-2021, MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), CHILLS (Chills), NAUSEA ( nausea) and VOMITING (vomiting) had resolved. On 21-Apr-2021, PYREXIA (fever) and FATIGUE (fatigue) had resolved and HEADACHE (headache) outcome was unknown.            No concomitant medication were provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-084205 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Significant Followup Appended. 2nd dose was updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-084205:Case for dose 2 of Husband
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vomiting
Clinical narrative: fever; fatigue; headache; Chills; nausea; vomiting; Muscle pain; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), PYREXIA (fever), FATIGUE (fatigue) and HEADACHE (headache) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 042B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), CHILLS (Chills) and NAUSEA ( nausea). 14-Apr-2021, the patient experienced VOMITING (vomiting). On 19-Apr-2021, the patient experienced PYREXIA (fever) and FATIGUE (fatigue). 19-Apr-2021, the patient experienced HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and PROMETHAZINE (PHENERGAN [PROMETHAZINE]) at a dose of 1 dosage form. On 17-Apr-2021, MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), CHILLS (Chills), NAUSEA ( nausea) and VOMITING (vomiting) had resolved. On 21-Apr-2021, PYREXIA (fever) and FATIGUE (fatigue) had resolved and HEADACHE (headache) outcome was unknown.            No concomitant medication were provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-084205 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Significant Followup Appended. 2nd dose was updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-084205:Case for dose 2 of Husband
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Pain at the site; Little fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at the site) and PYREXIA (Little fever) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION SITE PAIN (Pain at the site) and PYREXIA (Little fever). At the time of the report, VACCINATION SITE PAIN (Pain at the site) and PYREXIA (Little fever) outcome was unknown.            No concomitant medications were reported. No laboratory details were  provided. No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-021366 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: follow-up received on 24-May-2021: no new information received
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Fatigue
Clinical narrative: Her body felt like really heavy like a toner weight; extreme fatigue, spending most of the day resting; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (Her body felt like really heavy like a toner weight) and FATIGUE (extreme fatigue, spending most of the day resting) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (Her body felt like really heavy like a toner weight) and FATIGUE (extreme fatigue, spending most of the day resting). At the time of the report, DISCOMFORT (Her body felt like really heavy like a toner weight) and FATIGUE (extreme fatigue, spending most of the day resting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information and concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Injection site pruritus, Rash macular, Vaccination site erythema, Vaccination site induration, Vaccination site pain
Clinical narrative: shoulder area near the injection site became red; shoulder area near the injection site became swollen; shoulder area near the injection site became tight; shoulder area near the injection site became itchy; shoulder area near the injection site had a blotchy redness; Right arm felt sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (shoulder area near the injection site became red), VACCINATION SITE SWELLING (shoulder area near the injection site became swollen), VACCINATION SITE INDURATION (shoulder area near the injection site became tight), INJECTION SITE PRURITUS (shoulder area near the injection site became itchy) and RASH MACULAR (shoulder area near the injection site had a blotchy redness) in a 54-year-old male patient who received mRNA-1273 (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (shoulder area near the injection site became red), VACCINATION SITE SWELLING (shoulder area near the injection site became swollen), VACCINATION SITE INDURATION (shoulder area near the injection site became tight), INJECTION SITE PRURITUS (shoulder area near the injection site became itchy), RASH MACULAR (shoulder area near the injection site had a blotchy redness) and VACCINATION SITE PAIN (Right arm felt sore). On 09-Apr-2021, VACCINATION SITE ERYTHEMA (shoulder area near the injection site became red), VACCINATION SITE SWELLING (shoulder area near the injection site became swollen), VACCINATION SITE INDURATION (shoulder area near the injection site became tight), INJECTION SITE PRURITUS (shoulder area near the injection site became itchy), RASH MACULAR (shoulder area near the injection site had a blotchy redness) and VACCINATION SITE PAIN (Right arm felt sore) had resolved. Not Provided      The action taken with mRNA-1273 (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: shoulder area near the injection site became red; shoulder area near the injection site became swollen; shoulder area near the injection site became tight; shoulder area near the injection site became itchy; shoulder area near the injection site had a blotchy redness; Right arm felt sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (shoulder area near the injection site became red), VACCINATION SITE SWELLING (shoulder area near the injection site became swollen), VACCINATION SITE INDURATION (shoulder area near the injection site became tight), INJECTION SITE PRURITUS (shoulder area near the injection site became itchy) and RASH MACULAR (shoulder area near the injection site had a blotchy redness) in a 54-year-old male patient who received mRNA-1273 (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (shoulder area near the injection site became red), VACCINATION SITE SWELLING (shoulder area near the injection site became swollen), VACCINATION SITE INDURATION (shoulder area near the injection site became tight), INJECTION SITE PRURITUS (shoulder area near the injection site became itchy), RASH MACULAR (shoulder area near the injection site had a blotchy redness) and VACCINATION SITE PAIN (Right arm felt sore). On 09-Apr-2021, VACCINATION SITE ERYTHEMA (shoulder area near the injection site became red), VACCINATION SITE SWELLING (shoulder area near the injection site became swollen), VACCINATION SITE INDURATION (shoulder area near the injection site became tight), INJECTION SITE PRURITUS (shoulder area near the injection site became itchy), RASH MACULAR (shoulder area near the injection site had a blotchy redness) and VACCINATION SITE PAIN (Right arm felt sore) had resolved. Not Provided      The action taken with mRNA-1273 (Intramuscular) was unknown.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue
Clinical narrative: normally she exercises but she don't have the energies; extreme fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (normally she exercises but she don't have the energies) and FATIGUE (extreme fatigue) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (normally she exercises but she don't have the energies) and FATIGUE (extreme fatigue). At the time of the report, ASTHENIA (normally she exercises but she don't have the energies) and FATIGUE (extreme fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Patient was not under any medication.   Since the shot patient had extreme fatigue. The patient was spending most of the day resting, had to force herself to do what she needs to do, since she works from home, she was super super fatigue, really bad. Her body felt like really heavy like a toner weight. The patient was making sure to drink more water, normally she exercises but she did not have the energies.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Heart rate, Heart rate increased
Clinical narrative: dizzy; racing heart; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy) and HEART RATE INCREASED (racing heart) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included Drug allergy (bactrim).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizzy) and HEART RATE INCREASED (racing heart). At the time of the report, DIZZINESS (dizzy) and HEART RATE INCREASED (racing heart) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: 76,90 (High) increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant details were provided No treatment details were provided